Biote (BTMD) Equity Average (2021 - 2026)

Biote (BTMD) has reported Equity Average for 6 consecutive years, with -$53.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Equity Average rose 43.06% year-over-year to -$53.2 million; the TTM figure through Mar 2026 stood at -$53.2 million (up 43.06% YoY), while the FY2025 annual figure was -$80.4 million, down 15.85% from the prior year.
• Equity Average came in at -$53.2 million for Q1 2026 at Biote, up from -$62.0 million in the prior quarter.
• The five-year high for Equity Average was $7.4 million in Q1 2022, with the low at -$134.1 million in Q3 2024.
• Average Equity Average over 5 years is -$68.2 million, with a median of -$71.0 million recorded in 2023.
• The largest YoY upside for Equity Average was 153.76% in 2022 against a maximum downside of 4758.04% in 2022.
• Year by year, Equity Average stood at -$64.6 million in 2022, then surged by 31.99% to -$43.9 million in 2023, then sank by 160.81% to -$114.5 million in 2024, then surged by 45.85% to -$62.0 million in 2025, then climbed by 14.12% to -$53.2 million in 2026.
• According to Business Quant data, Equity Average over the past three periods registered -$53.2 million, -$62.0 million, and -$72.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.